期刊文献+

胸腺扩大切除术治疗重症肌无力的远期疗效 被引量:2

Long-term Effectiveness of Extended Thymectomy in the Treatment of Myasthenia Gravis
原文传递
导出
摘要 目的评价胸腺扩大切除术术后重症肌无力(myasthenia gravis,MG)的远期疗效及预后的影响因素。方法回顾性分析2005年1月至2010年12月我院共施行胸腺扩大切除术治疗重症肌无力45例患者的临床资料,其中男11例、女34例,年龄32.6(16~50)岁。对所有患者进行随访,计算有效率,了解疗效随时间的变化,并对患者性别、年龄、Osserman分型、病理类型进行单因素分析。结果 45例完成随访,随访率100%,随访时间58.3(36~108)个月。有效率80.0%(36/45),随访时间越长有效率越高。影响重症肌无力疗效的单因素分析表明,性别(P=0.666)不是MG预后的影响因素,而年龄(P=0.019)、Osserman分型(P=0.024)和病理类型(P=0.043)是预后的影响因素。结论胸腺扩大切除术远期疗效满意,且随访时间越长预后更好。 Objective To assess the long-term efficacy of extended thymectomy in the treatment of myasthenia gravis(MG) and the factors influencing the results. Methods We retrospectively analyzed the clinical data of 45 MG patients who underwent extended thymectomy in our hospital from January 2005 through December 2010. There were 11 males and 34 females at age of 32.6(16-50) years. The overall effective rate was calculated. Univariate analysis was used to analyze the risk factors including sex,age,Osserman classification,and pathological type for outcomes. Results All the patients were followed up for a mean of 58.3 months(ranged from 36 to 108 months). The overall effective rate was 80.0%(36/45) and rose with the extention of time. Age(P=0.019),pathological type(P=0.024) of thymus and Osserman classification(P=0.043) of MG were the main factors influencing the outcomes of the treatment except sex(P=0.666). Conclusion Extended thymectomy in the treatment of MG has better outcomes. And the overall effective rate rises with the extention of time.
出处 《中国胸心血管外科临床杂志》 CAS CSCD 2015年第12期1114-1116,共3页 Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
关键词 胸腺切除 重症肌无力 疗效 Thymectomy Myasthenia gravis Long-term effectiveness
  • 相关文献

参考文献15

  • 1Joseph B. Shrager,Derek Nathan,Clayton J. Brinster,Omair Yousuf,Abraham Spence,Zhen Chen,Larry R. Kaiser.Outcomes After 151 Extended Transcervical Thymectomies for Myasthenia Gravis[J]. The Annals of Thoracic Surgery . 2006 (5)
  • 2Nezih ?zdemir,Murat Kara,Erkan Dikmen,Aydin Nadir,Murat Akal,Nezih Yücemen,?inasi Yavuzer.Predictors of clinical outcome following extended thymectomy in myasthenia gravis[J]. European Journal of Cardio-Thoracic Surgery . 2003 (2)
  • 3Lawrence E. Stern,Michael S. Nussbaum,John G. Quinlan,Josef E. Fischer.Long-term evaluation of extended thymectomy with anterior mediastinal dissection for myasthenia gravis[J]. Surgery . 2001 (4)
  • 4Gary S. Gronseth,Richard J. Barohn.Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology[J]. Neurology . 2000 (1)
  • 5ALFRED BLALOCK,M. F. MASON,HUGH J. MORGAN,S. S. RIVEN.MYASTHENIA GRAVIS AND TUMORS OF THE THYMIC REGION: REPORT OF A CASE IN WHICH THE TUMOR WAS REMOVED[J]. Annals of Surgery . 1939 (4)
  • 6DeFilippi VJ,Richman DP,Ferguson MK.Transcervical thymectomy for myasthenia gravis. The Annals of Thoracic Surgery . 1994
  • 7LIU Cheng-wu,LUO Meng,MEI Jian-dong,ZHU Yun-ke,PU Qiang,MA Lin,CHE Guo-wei,LIN Yi-dan,WU Zhu,WANG Yun,KOU Ying-li,LIU Lun-xu.Perioperative and long-term outcome of thymectomy for myasthenia gravis: comparison of surgical approaches and prognostic analysis[J].Chinese Medical Journal,2013(1):34-40. 被引量:9
  • 8Victor Tomulescu,Virginia Ion,Andras Kosa,Olivia Sgarbura,Irinel Popescu.Thoracoscopic Thymectomy Mid-Term Results. The Annals of Thoracic Surgery . 2006
  • 9Kumar Nilkamal,Verma A K,Mishra A,Agrawal G,Agrawal A,Misra U K,Mishra S K.Factors predicting surgical outcome of thymectomy in myasthenia gravis: A 16-year experience. Annals of Indian Academy of Neurology . 2012
  • 10Gripp S,Hilgers K,Wurm R,et al.Thymoma: prognostic factors and treatment outcomes. Cancer . 1998

二级参考文献26

  • 1Conti-Fine BM, Milani M, Kaminski HJ. Myasthenia gravis:past, present, and future. J Clin Invest 2006; 116: 2843-2854.
  • 2Jaretzki A 3rd, Barohn RJ, Emstoff RM, Kaminski HJ,Keesey JC, Penn AS, et al. Myasthenia gravis:recommendations for clinical research standards. Task Forceof the Medical Scientific Advisory Board of the MyastheniaGravis Foundation of America. Ann Thorac Surg 2000; 70:327-334.
  • 3Blalock A, Mason MF, Morgan HJ, Riven SS. Myastheniagravis and tumors of the thymic region: report of a case inwhich the tumor was removed. Ann Surg 1939; 110: 544-561.
  • 4Bachmann K, Burkhardt D,Schreiter I,Kaifi J, Schurr P,Busch C, et al. Thymectomy is more effective thanconservative treatment for myasthenia gravis regardingoutcome 'and clinical improvement. Surgery 2009; 145:392-398.
  • 5Murthy JM. Thymectomy in myasthenia gravis. NeurologyIndia 2009; 57:363-365.
  • 6Jaretzki A 3rd. Thymectomy for myasthenia gravis: ananalysis of the controversies regarding technique and results.Neurology 1997; 48 Suppl 5: S52-S63.
  • 7Manlulu A, Lee TW, Wan I,Law CY, Chang C, Garzon JC, etal. Video-assisted thoracic surgery thymectomy fornonthymatous myasthenia gravis. Chest 2005; 128:3454-3460.
  • 8Tomulescu V,Ion V, Kosa A, Sgarbura O, Popescu I.Thoracoscopic thymectomy mid-term results. Ann ThoracSurg 2006; 82: 1003-1008.
  • 9Lin MW, Chang YL, Huang PM, Lee YC. Thymectomy fornon-thymomatous myasthenia gravis: a comparison ofsurgical methods and analysis of prognostic factors. Eur JCardiothorac Surg 2010; 37: 7-12.
  • 10Ruckert JC, Walter M, Muller JM. Pulmonary function afterthoracoscopic thymectomy versus median sternotomy formyasthenia gravis. Ann Thora Surg 2000; 70: 1656-1661.

共引文献8

同被引文献10

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部